Improving therapy adherence with smart dispenser Sensemedic

Many patients find it difficult to take their medication according to the schedule that the doctor has given to them. If the schedules for the medications are irregular, breaks are inserted or there are many different types of medication to be taken, adherence can be very challenging.

Miriam van de Loo, director of Brocacef Maatmedicatie, says in the newspaper De Stad Amersfoort: “We are talking about thirty to forty percent of the drug users. The percentage is even higher for people with long-term illnesses, up to seventy percent.”

We can find many devices in the market with the goal to improve therapy adherence. However a simple smart dispenser with an alarm that alerts patients when it is time to take their medication, is not enough: a combination of remembering the medication intake and support by healthcare professionals is needed.

Evalan has developed an IoT solution that helps those patients to adhere to their medication intake with multilateral support: Sensemedic.

Sensemedic was developed in cooperation with AstraZeneca. It is a smart medicine box with different compartments filled depending on the treatment and it works independently. The patient only needs to take the medication without having to connect the dispenser to a telephone or an app. The sensor detects when a medicine is removed or added to the dispenser, in this way it can be accurately determined whether the patient complies to the medication schedule prescribed by the doctor. Finally, healthcare professionals can view the data so the patient can be guided and supported in a more targeted way.

Furthermore, a text message will be sent to the patient when intake is forgotten. Based on the real-time measurement data, the text message is automatically sent within one hour of the elapsed intake time.

Sensemedic in Hong Kong

Sensemedic in Hong Kong

Evalan started delivering Sensemedic services in Hong Kong to lung cancer patients. These services are delivered as part of a trial project with 200 patients.

Sensemedic is Evalan’s “Real Time Medication Monitoring” system which supports medication adherence improvements. Each participating patient uses Sensemedic’s smart medication dispenser that collects medication intake information in real time. This enables Sensemedic to provide smart reminding functions to the patient, and to deliver detailed information about medication intake to designated healthcare professionals so they can guide and support patients from existing behaviour towards a better intake pattern.

For the project in Hong Kong, Sensemedic’s portal functionalities were expanded to include questionnaires, which are sent periodically to patients in accordance with the trial schedule.

This project will run for at least 2 years.

Sensemedic in Hong Kong

FDA Approval Sensemedic for US

FDA Approval Sensemedic for US

Evalan has received approval from the US Food and Drug Administration (FDA) to distribute and sell Sensemedic to the US market. Sensemedic has been available in Europe, Asia and Africa since 2007 and will now also be available in the US.

Support patients towards a better intake pattern

Sensemedic is smart medication reminding system that can improve medication adherence. It uses a proprietary medication dispenser with real-time communication technology. This dispenser monitors the intake behaviour of patients. The information that is collected by the dispenser makes it possible to remind patients to take their medication if they forget, and for healthcare professionals to guide and support patients from existing behaviour towards a better intake pattern.

Evalan helps pharmaceutical companies and research institutes

Evalan offers Sensemedic to healthcare institutions, pharmaceutical companies and research institutes. The FDA approval is an important step for Sensemedic as there is significant interest in the US for systems that help improve medication adherence. This interest is also driven by a desire to introduce more self-management in patient care, and by concerns about rising healthcare costs.

FDA Approval Sensemedic for US